Literature DB >> 23290849

[Estimates and prediction on incidence, mortality and prevalence of breast cancer in China, 2008].

Min-Lu Zhang1, Zhe-Zhou Huang, Ying Zheng.   

Abstract

OBJECTIVE: To estimate the incidence, mortality and 5-year prevalence of breast cancer in China, in 2008.
METHODS: Data from 36 cancer registries and the Third National Death Survey in China (2004 - 2005) were used to estimate the incidence, mortality and 5-year prevalence of breast cancer in China in 2008. Mathematical models were used to predict the breast cancer incidence and mortality in the next 20 years.
RESULTS: In 2008, the incidence of breast cancer was 169 452 (14.2%) with the incidence rate of 21.6/100 000, ranking the second among all the cancers. Deaths due to breast cancer was 44 908 (6.1%) with mortality as 5.7/100 000, which ranked the sixth among all the cancers. The 5-year prevalence rate of breast cancer in China was 120.8/100 000, taking up the proportion as 26.1%, ranking the first among all the cancers. Breast cancer was seen more frequently among people aged between 40 to 70. Our data on prediction showed that the incidence and mortality of breast cancer in China would gradually increase in the next 20 years.
CONCLUSION: Breast cancer was the second cause of incidence rates among all the cancers in China, with both increasing incidence and mortality. Population at most risk for breast cancer were those aged 40 to 70, who deserved special programs for prevention and control.

Entities:  

Mesh:

Year:  2012        PMID: 23290849

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  14 in total

1.  Frequent epigenetic inactivation of RSK4 by promoter methylation in cancerous and non-cancerous tissues of breast cancer.

Authors:  Qiuyun Li; Yi Jiang; Wei Wei; Yinan Ji; Hui Gao; Jianlun Liu
Journal:  Med Oncol       Date:  2013-12-11       Impact factor: 3.064

2.  [Key technologies in digital breast tomosynthesis system:theory, design, and optimization].

Authors:  Mingqiang Li; Kun Ma; Xi Tao; Yongbo Wang; Ji He; Ziquan Wei; Geofeng Chen; Sui Li; Dong Zeng; Zhaoying Bian; Guohui Wu; Shan Liao; Jianhua Ma
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-02-28

3.  Cytotoxic T lymphocyte associated antigen 4 expression predicts poor prognosis in luminal B HER2-negative breast cancer.

Authors:  Gaochen Lan; Jie Li; Qiaomei Wen; Lin Lin; Libin Chen; Liyu Chen; Xi Chen
Journal:  Oncol Lett       Date:  2018-02-07       Impact factor: 2.967

4.  HER2 status in molecular apocrine breast cancer: associations with clinical, pathological, and molecular features.

Authors:  Wenwen Guo; Wei Wang; Yun Zhu; Xiaojing Zhu; Zhongyuan Shi; Yan Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

5.  Preliminary effectiveness of breast cancer screening among 1.22 million Chinese females and different cancer patterns between urban and rural women.

Authors:  Yubei Huang; Hongji Dai; Fengju Song; Haixin Li; Ye Yan; Zhenhua Yang; Zhaoxiang Ye; Sheng Zhang; Hong Liu; Yali Cao; Li Xiong; Yahong Luo; Tie Pan; Xiangjun Ma; Jie Wang; Xiuling Song; Ling Leng; Yeping Zhang; Jie Sun; Jialin Wang; Hengmin Ma; Lingzhi Kong; Zhenglong Lei; Yaogang Wang; Wang Peishan; Jiali Han; Xishan Hao; Kexin Chen
Journal:  Sci Rep       Date:  2016-12-20       Impact factor: 4.379

6.  Effect of EME1 exon variant Ile350Thr on risk and early onset of breast cancer in southern Chinese women.

Authors:  Jianwei Zhao; Lin Liu; Anqing Zhang; Qin Chen; Wenxiang Fang; Lizhi Zeng; Jiachun Lu
Journal:  J Biomed Res       Date:  2013-04-15

7.  A polymorphism at the 3'-UTR region of the aromatase gene is associated with the efficacy of the aromatase inhibitor, anastrozole, in metastatic breast carcinoma.

Authors:  Lei Liu; Yu-Xian Bai; Jian-Hua Zhou; Xiu-Wei Sun; Hong Sui; Wen-Jie Zhang; Heng-Heng Yuan; Rui Xie; Xiao-Li Wei; Ting-Ting Zhang; Peng Huang; Yan-Jing Li; Jing-Xuan Wang; Shu Zhao; Qing-Yuan Zhang
Journal:  Int J Mol Sci       Date:  2013-09-13       Impact factor: 5.923

8.  The prevalence of BRCA1/2 mutations of triple-negative breast cancer patients in Xinjiang multiple ethnic region of China.

Authors:  Yong Tao Li; Duo Ni; Liang Yang; Qian Zhao; Jiang Hua Ou
Journal:  Eur J Med Res       Date:  2014-06-25       Impact factor: 2.175

9.  Gemcitabine resistance in breast cancer cells regulated by PI3K/AKT-mediated cellular proliferation exerts negative feedback via the MEK/MAPK and mTOR pathways.

Authors:  Xiao Li Yang; Feng Juan Lin; Ya Jie Guo; Zhi Min Shao; Zhou Luo Ou
Journal:  Onco Targets Ther       Date:  2014-06-13       Impact factor: 4.147

10.  Thirty Years Cancer Incidence Data for Lahore, Pakistan: Trends and Patterns 1984-2014

Authors:  Andleeb Masood; Khalid Masood; Mazhar Hussain; Waqar Ali; Masooma Riaz; Zafar Alauddin; Munir Ahmad; Misbah Masood; Abubaker Shahid
Journal:  Asian Pac J Cancer Prev       Date:  2018-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.